Lorvotuzumab

Tax included
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine.
MedChemExpress 
HY-P99372

Data sheet

Size
Multiple sizes
Reactivity
ADC Antibody
Application
Cancer-programmed cell death
CAS
339306-30-8